Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Investigation|March 19, 2019
Platelet reactivity patterns in patients treated with dual antiplatelet therapyMax-Paul Winter, Theresia Schneeweiss, Rolf Cremer, et al.
Scientific Reports|July 2, 2024
Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with EmpagliflozinMartin Benedikt, Faisal Aziz, Thomas Fröschl, et al.
Frontiers in Cardiovascular Medicine|September 2, 2022
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancerFlorian Posch, Tobias Niedrist, Theresa Glantschnig, et al.
European Journal of Clinical Investigation|June 8, 2020
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patientsGloria M Gager, Bernd Jilma, Max-Paul Winter, et al.
Wiener Klinische Wochenschrift|May 4, 2022
Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of CardiologyJutta Bergler-Klein, Peter P Rainer, Markus Wallner, et al.
The Journal of Trauma and Acute Care Surgery|January 21, 2017
Acute right heart failure after hemorrhagic shock and trauma pneumonectomy-a management approach: A blinded randomized controlled animal trial using inhaled nitric oxideAndrea L Lubitz, Lars O Sjoholm, Amy Goldberg, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 26, 2023
Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trialCaren Sourij, Faisal Aziz, Norbert J Tripolt, et al.
Cardiovascular Diabetology|July 5, 2023
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trialMartin Benedikt, Harald Mangge, Faisal Aziz, et al.
Heart (British Cardiac Society)|July 30, 2013
Bile acids induce arrhythmias in human atrial myocardium--implications for altered serum bile acid composition in patients with atrial fibrillationPeter P Rainer, Uwe Primessnig, Sandra Harenkamp, et al.
Oncotarget|May 18, 2017
Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardiumMarkus Wallner, Mounir Khafaga, Ewald Kolesnik, et al.
Pageof 8